Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6122796 | Journal of Infection | 2016 | 9 Pages |
Abstract
There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
German A. Contreras, Cynthia S. Bell, Gabriela Del Bianco, Norma Pérez, Laura Benjamins, Matthew T. Kleinosky, Gilhen Rodriguez, James R. Murphy, Gloria P. Heresi,